The Relationship of Bacterial Vaginosis, Candida and Trichomonas Infection to Symptomatic Vaginitis in Postmenopausal Women Attending a Vaginitis Clinic
Overview
Affiliations
Objective: To estimate the prevalence of bacterial vaginosis, Candida albicans, and Trichomonas vaginalis infections in a population of postmenopausal women with symptoms of vaginitis seen at a vaginitis clinic either as self-referred or clinician referred patients.
Methods: A cross-sectional study of 148 postmenopausal women (cases) and 1564 controls of reproductive age attending a vaginitis clinic. C. albicans and T. vaginalis infections were diagnosed by culture techniques. Bacterial vaginosis was diagnosed on the basis of clinical findings.
Results: Fifty-six (37.8%) postmenopausal women and 834 (53.3%) controls were diagnosed with T. vaginalis or C. albicans infection, or bacterial vaginosis, or mixed infection (odds ratio (OR) 0.53, 95% confidence interval (CI) 0.37-0.75). C. albicans and T. vaginalis infection were diagnosed in 34.1% (534/1564) and 1.92% (30/1564) of women of childbearing age and in 13.5% (20/148) and 10.8% of postmenopausal women, respectively. (P < 0.05 for both comparisons). The prevalence of bacterial vaginosis was similar between the two groups (14/148 in postmenopausal patients and 210/1564 in controls of reproductive age; P = 0.22).
Conclusions: Among postmenopausal women attending a vaginitis clinic, a defined diagnosis of bacterial vaginosis, C. albicans or T. vaginalis infection can be made in about one third of such patients. Concerning the two thirds of symptomatic women lacking such a microbiologic diagnosis, alternative causes (e.g., estrogen deficiency, nonanaerobic bacterial infections, local irritants or allergenes, and dermatologic conditions) need to be considered.
Amadi S, Mkpe A, Awopeju A, Iwo-Amah R, Olobuah A Niger Med J. 2024; 63(5):348-355.
PMID: 38867752 PMC: 11165321.
The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection.
Harding A, Heaton N Cancers (Basel). 2022; 14(4).
PMID: 35205657 PMC: 8870346. DOI: 10.3390/cancers14040909.
Pereira L, Correia A, da Silva Z, de Resende C, Brandao F, Almeida R Eur J Clin Microbiol Infect Dis. 2021; 40(8):1681-1693.
PMID: 33713006 PMC: 8295079. DOI: 10.1007/s10096-021-04199-1.
dEnfert C, Kaune A, Alaban L, Chakraborty S, Cole N, Delavy M FEMS Microbiol Rev. 2020; 45(3).
PMID: 33232448 PMC: 8100220. DOI: 10.1093/femsre/fuaa060.
McGovern A, Hogg M, Shields B, Sattar N, Holman R, Pearson E BMJ Open Diabetes Res Care. 2020; 8(1).
PMID: 32448787 PMC: 7252998. DOI: 10.1136/bmjdrc-2020-001238.